Proniosome: A Promising Approach for Vesicular Drug Delivery

Overview

Journal Turk J Pharm Sci

Specialty Pharmacology

Date 2022 Sep 1

PMID 36047601

Authors

Marzina Ajrin

Fahmida Anjum

Affiliations

Soon will be listed here.

Abstract

Different types of drug delivery systems are intended to deliver therapeutic agents to the appropriate site of interest to get desired pharmacological effect. In the field of drug delivery, the advancement of nanotechnology helps develop novel dosage forms such as liposome, noisome, and proniosome. Proniosomes are promising drug carriers, that are dry formulations, and after hydration, are converted to noisome dispersion. Dry proniosomal powder can deliver a unit dose of the drug with improved drug stability and solubility. By using this formulation, both the hydrophilic and lipophilic drugs can be delivered through different routes like oral, topical, transdermal, vaginal, . This review revolves on different features of proniosomes such as their structure, formulation materials of proniosomes, preparation methods, evaluation, and application.

Citing Articles

Bioadhesive hybrid system of niosomes and pH sensitive gel for itraconazole ocular delivery: Dual approach for efficient treatment of fungal infections.

Badran M, Alsubaie A, Bekhit M, Alomrani A, Almomen A, Ibrahim M Saudi Pharm J. 2024; 32(12):102208.

PMID: 39697473 PMC: 11653644. DOI: 10.1016/j.jsps.2024.102208.

Lipid-based nanoparticles as a promising treatment for the skin cancer.

Golestani P Heliyon. 2024; 10(9):e29898.

PMID: 38698969 PMC: 11064151. DOI: 10.1016/j.heliyon.2024.e29898.

Novasomes as Nano-Vesicular Carriers to Enhance Topical Delivery of Fluconazole: A New Approach to Treat Fungal Infections.

Fatima I, Rasul A, Shah S, Saadullah M, Islam N, Khames A Molecules. 2022; 27(9).

PMID: 35566287 PMC: 9103678. DOI: 10.3390/molecules27092936.

References

Sahoo R, Biswas N, Guha A, Kuotsu K . Maltodextrin based proniosomes of nateglinide: bioavailability assessment. Int J Biol Macromol. 2014; 69:430-4. DOI: 10.1016/j.ijbiomac.2014.05.075. View

Mehta M, Dureja H, Garg M . Development and optimization of boswellic acid-loaded proniosomal gel. Drug Deliv. 2016; 23(8):3072-3081. DOI: 10.3109/10717544.2016.1149744. View

Schlich M, Lai F, Pireddu R, Pini E, Ailuno G, Fadda A . Resveratrol proniosomes as a convenient nanoingredient for functional food. Food Chem. 2019; 310:125950. DOI: 10.1016/j.foodchem.2019.125950. View

Tanaka T, Shnimizu M, Moriwaki H . Cancer chemoprevention by carotenoids. Molecules. 2012; 17(3):3202-42. PMC: 6268471. DOI: 10.3390/molecules17033202. View

Eldeeb A, Salah S, Ghorab M . Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study. Drug Deliv. 2019; 26(1):509-521. PMC: 6534210. DOI: 10.1080/10717544.2019.1609622. View

El-Laithy H, Shoukry O, Mahran L . Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm. 2010; 77(1):43-55. DOI: 10.1016/j.ejpb.2010.10.011. View

Abdelbary G, Aburahma M . Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain. J Liposome Res. 2014; 25(2):107-21. DOI: 10.3109/08982104.2014.941861. View

Kuzmov A, Minko T . Nanotechnology approaches for inhalation treatment of lung diseases. J Control Release. 2015; 219:500-518. DOI: 10.1016/j.jconrel.2015.07.024. View

Rhodes D . Maltodextrin-based proniosomes. AAPS PharmSci. 2001; 3(1):E1. PMC: 2751233. DOI: 10.1208/ps030101. View

10.

Souto E, Muller R . Cosmetic features and applications of lipid nanoparticles (SLN, NLC). Int J Cosmet Sci. 2008; 30(3):157-65. DOI: 10.1111/j.1468-2494.2008.00433.x. View

11.

Pardakhty A, Varshosaz J, Rouholamini A . In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm. 2006; 328(2):130-41. DOI: 10.1016/j.ijpharm.2006.08.002. View

12.

Alsarra I, Bosela A, Ahmed S, Mahrous G . Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm. 2005; 59(3):485-90. DOI: 10.1016/j.ejpb.2004.09.006. View

13.

Hao Y, Zhao F, Li N, Yang Y, Li K . Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm. 2002; 244(1-2):73-80. DOI: 10.1016/s0378-5173(02)00301-0. View

14.

Zupancic S, Lavric Z, Kristl J . Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature. Eur J Pharm Biopharm. 2015; 93:196-204. DOI: 10.1016/j.ejpb.2015.04.002. View

15.

Abu El-Enin A, Khalifa M, Dawaba A, Dawaba H . Proniosomal gel-mediated topical delivery of fluconazole: Development, characterization, and microbiological evaluation. J Adv Pharm Technol Res. 2019; 10(1):20-26. PMC: 6383348. DOI: 10.4103/japtr.JAPTR_332_18. View

16.

Salehi B, Mishra A, Nigam M, Sener B, Kilic M, Sharifi-Rad M . Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines. 2018; 6(3). PMC: 6164842. DOI: 10.3390/biomedicines6030091. View

17.

Rahman S, Abdelmalak N, Badawi A, Elbayoumy T, Sabry N, El Ramly A . Formulation of tretinoin-loaded topical proniosomes for treatment of acne: in-vitro characterization, skin irritation test and comparative clinical study. Drug Deliv. 2014; 22(6):731-9. DOI: 10.3109/10717544.2014.896428. View

18.

Naik , Kalia , Guy . Transdermal drug delivery: overcoming the skin's barrier function. Pharm Sci Technol Today. 2000; 3(9):318-326. DOI: 10.1016/s1461-5347(00)00295-9. View

19.

Prausnitz M, Langer R . Transdermal drug delivery. Nat Biotechnol. 2008; 26(11):1261-8. PMC: 2700785. DOI: 10.1038/nbt.1504. View

20.

Li Q, Li Z, Zeng W, Ge S, Lu H, Wu C . Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. Eur J Pharm Sci. 2014; 62:115-23. DOI: 10.1016/j.ejps.2014.05.020. View